To determine whether the DAGLA/2-AG axis enhances HCC progression by upregulating PHLDA2 expression, we examined the changes in PHLDA2 expression in HCC cells with different DAGLA levels. This evidence concerns the gene DAGLA and hepatocellular carcinoma.